1. |
Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104:1046-52.
|
2. |
Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103:634-7.
|
3. |
Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44:1690-9.
|
4. |
Tossios P, Krausgrill B, Schmidt M, et al. Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary infusion in pigs with reperfused myocardial infarction. Circulation 2008; 29:1911-21.
|
5. |
Li CJ, Gao RL, Liu YQ, et al. Differentiation and culture of endothelial progenitor cells from mini-swine peripheral blood in vitro. Chin J Pathophysiol 2005; 21:1230-3.
|
6. |
Li CJ, Gao RL, Yang YJ, et al. Implantation of autologous bone marrow mononuclear cells into ischemic myocardium enhances coronary capillaries and systolic function in miniswine. Chin Med Sci J 2008; 23:234-8.
|
7. |
Silva GV, Litovsky S, Assad J, et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005; 111:150-6.
|
8. |
Hirsch A, Nijveldt R, van der Vleuten PA, et al. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial. Catheter Cardiovasc Interv 2008; 71:273-81.
|
9. |
Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113:1287- 94.
|
10 |
Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106:1913-8.
|
11 |
Moelker AD, Baks T, van den Bos EJ, et al. Reduction in infarct size, but no functional improvement after bone marrow cell administration in a porcine model of reperfused myocardial infarction. Eur Heart J 2006; 27:3057- 64.
|
12 |
Dimmeler S, Burchfield J, Zeiher AM. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008; 28:208-16.
|
13 |
Assmus B, Schchinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002; 106:3009-17.
|
14 |
Katusic ZS. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004; 24:2021-7.
|
15 |
Rossig L, Urbich C, Dimmeler S. Endothelial progenitor cells at work: not mature yet, but already stress-resistant. Arterioscler Thromb Vase Biol 2004; 24:1977-9.
|